FDA approves second CAR-T cancer therapy to treat multiple myeloma, opening the door for greater access - STAT

The FDA has approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies.

The Food and Drug Administration on Monday approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies. The treatm… [+493 chars]

full article...